Celltrion Will Trial COVID-19 Antiviral From July

Company Identifies 14 Antibodies Most Potent For Neutralizing Coronavirus

Syringe_Covid19_Cell
Celltrion’s COVID-19 antiviral treatment enters the next phase of development • Source: Shutterstock

More from Products

More from Generics Bulletin